Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
Target selection is a key feature in cancer immunotherapy, a promising field in cancer research. In this respect, gangliosides, a broad family of structurally related glycolipids, were suggested as potential targets for cancer immunotherapy based on their higher abundance in tumors when compared wit...
Saved in:
| Main Authors: | Julien Fleurence, Sophie Fougeray, Meriem Bahri, Denis Cochonneau, Béatrice Clémenceau, François Paris, Andras Heczey, Stéphane Birklé |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2017/5604891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gangliosides in milk
by: Slavica Potočki, et al.
Published: (2016-07-01) -
The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells
by: Victoria Hein, et al.
Published: (2025-07-01) -
EDF1 accelerates ganglioside GD3 accumulation to boost CD52-mediated CD8+ T cell dysfunction in neuroblastoma
by: Di Li, et al.
Published: (2025-02-01) -
Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
by: Amy N Courtney, et al.
Published: (2025-03-01) -
Botulinum neurotoxin A mutants with enhanced ganglioside binding show improved potency and altered ganglioside selectivity
by: Geoffrey Masuyer, et al.
Published: (2025-06-01)